Detalles de la búsqueda
1.
α-FAtE: A new predictive score of response to atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma.
Int J Cancer;
154(6): 1043-1056, 2024 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37994647
2.
Impact of body mass index on the prognosis of unresectable HCC patients receiving first-line Lenvatinib or atezolizumab plus bevacizumab.
Liver Int;
44(5): 1108-1125, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38517286
3.
Etiological changes of liver cirrhosis and hepatocellular carcinoma-complicated liver cirrhosis in Japan: Updated nationwide survey from 2018 to 2021.
Hepatol Res;
2024 Apr 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38638067
4.
Prophylactic tenofovir alafenamide for hepatitis B virus reactivation and reactivation-related hepatitis.
J Med Virol;
95(2): e28452, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36597900
5.
Role of the Prognostic Nutritional Index in Predicting Survival in Advanced Hepatocellular Carcinoma Treated with Atezolizumab Plus Bevacizumab.
Oncology;
101(5): 283-291, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36657420
6.
Hepatitis C virus eradication by direct-acting antivirals causes a simultaneous increase in the prevalence of fatty liver and hyper low-density lipoprotein cholesterolemia without an increase in body weight.
Hepatol Res;
53(7): 595-606, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-36945790
7.
Recent prevalence and characteristics of patients with hepatitis delta virus in Hokkaido, Japan.
Hepatol Res;
53(10): 960-967, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37332115
8.
Prediction Model with HLA-A*33:03 Reveals Number of Days to Develop Liver Cancer from Blood Test.
Int J Mol Sci;
24(5)2023 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36902191
9.
Incidence of post-transplant hepatitis B virus reactivation with the use of kidneys from donors with resolved hepatitis B virus infection.
J Viral Hepat;
29(11): 976-985, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36031873
10.
Effects of nucleos(t)ide analogs on hepatitis B surface antigen reduction with interferon-lambda 3 induction in chronic hepatitis B patients.
Hepatol Res;
52(7): 586-596, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35352445
11.
Overestimated renal function in patients with liver cirrhosis predicts poor prognosis.
Hepatol Res;
52(7): 603-613, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35352857
12.
The potential of soluble CD14 in discriminating nonalcoholic steatohepatitis from nonalcoholic fatty liver disease.
Hepatol Res;
52(6): 508-521, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35129841
13.
Validation of the easy-to-use lenvatinib prognostic index to predict prognosis in advanced hepatocellular carcinoma patients treated with lenvatinib.
Hepatol Res;
52(12): 1050-1059, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-35960789
14.
Lenvatinib suppresses cancer stem-like cells in HCC by inhibiting FGFR1-3 signaling, but not FGFR4 signaling.
Carcinogenesis;
42(1): 58-69, 2021 02 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32449510
15.
Changes in the estimated renal function after hepatitis C virus eradication with direct-acting antiviral agents: Impact of changes in skeletal muscle mass.
J Viral Hepat;
28(5): 755-763, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33587828
16.
Successful treatment by on-demand glecaprevir and pibrentasvir for hepatitis C flare during R-CHOP in patients with diffuse large B-cell lymphoma: a case report.
BMC Infect Dis;
21(1): 389, 2021 Apr 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-33906643
17.
Early response and safety of atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma in patients who do not meet IMbrave150 eligibility criteria.
Hepatol Res;
51(9): 979-989, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34245216
18.
Recent advances in the treatment of hepatitis C virus infection for special populations and remaining problems.
J Gastroenterol Hepatol;
36(5): 1152-1158, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-32667068
19.
Time-dependent changes in the seroprevalence of COVID-19 in asymptomatic liver disease outpatients in an area in Japan undergoing a second wave of COVID-19.
Hepatol Res;
50(10): 1196-1200, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32729953
20.
Analysis of the optimal psoas muscle mass index cut-off values, as measured by computed tomography, for the diagnosis of loss of skeletal muscle mass in Japanese people.
Hepatol Res;
50(6): 715-725, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32202371